| Full Journal Title | JCR Abbreviated Title | Journal Impact Factor | IF without Journal Self Cites | Quartile | Category | Rank in This Category | Totals |
| Targeted Oncology | TARGET ONCOL | 3.438 | 3.354 | Q2 | ONCOLOGY | 87 | 217 |
| TECHNICAL PHYSICS | TECH PHYS+ | 0.632 | 0.507 | Q4 | PHYSICS, APPLIED | 136 | 147 |
| TECHNICAL PHYSICS LETTERS | TECH PHYS LETT+ | 0.771 | 0.644 | Q4 | PHYSICS, APPLIED | 126 | 147 |
| Techniques in Coloproctology | TECH COLOPROCTOL | 2.342 | 2.026 | Q3 | GASTROENTEROLOGY & HEPATOLOGY | 52 | 79 |
| TECHNOLOGY AND HEALTH CARE | TECHNOL HEALTH CARE | 0.724 | 0.636 | Q4 | ENGINEERING, BIOMEDICAL | 70 | 77 |
| TECHNOLOGY IN CANCER RESEARCH & TREATMENT | TECHNOL CANCER RES T | 2.204 | 2.134 | Q3 | ONCOLOGY | 150 | 217 |
| TECHNOLOGY REVIEW | TECHNOL REV | 0.300 | 0.300 | Q4 | MULTIDISCIPLINARY SCIENCES | 60 | 64 |
| TENSIDE SURFACTANTS DETERGENTS | TENSIDE SURFACT DET | 0.869 | 0.664 | Q3 | CHEMISTRY, APPLIED | 54 | 72 |
| TENSIDE SURFACTANTS DETERGENTS | TENSIDE SURFACT DET | 0.869 | 0.664 | Q4 | CHEMISTRY, PHYSICAL | 125 | 145 |
| TENSIDE SURFACTANTS DETERGENTS | TENSIDE SURFACT DET | 0.869 | 0.664 | Q3 | ENGINEERING, CHEMICAL | 97 | 135 |
| TETRAHEDRON-ASYMMETRY | TETRAHEDRON-ASYMMETR | 2.126 | 1.861 | Q3 | CHEMISTRY, PHYSICAL | 80 | 145 |
| TETSU TO HAGANE-JOURNAL OF THE IRON AND STEEL INSTITUTE OF JAPAN | TETSU TO HAGANE | 0.381 | 0.242 | Q4 | METALLURGY & METALLURGICAL ENGINEERING | 59 | 74 |
| THEORETICAL AND APPLIED FRACTURE MECHANICS | THEOR APPL FRACT MEC | 2.659 | 2.273 | Q1 | ENGINEERING, MECHANICAL | 24 | 130 |
| THEORETICAL AND APPLIED FRACTURE MECHANICS | THEOR APPL FRACT MEC | 2.659 | 2.273 | Q1 | MECHANICS | 21 | 133 |
| THEORETICAL AND COMPUTATIONAL FLUID DYNAMICS | THEOR COMP FLUID DYN | 1.097 | 1.048 | Q3 | MECHANICS | 96 | 133 |
| Theoretical and Experimental Chemistry | THEOR EXP CHEM+ | 0.500 | 0.292 | Q4 | CHEMISTRY, MULTIDISCIPLINARY | 149 | 166 |
| THEORETICAL AND MATHEMATICAL PHYSICS | THEOR MATH PHYS+ | 0.984 | 0.815 | Q3 | PHYSICS, MULTIDISCIPLINARY | 49 | 79 |
| Theoretical Biology and Medical Modelling | THEOR BIOL MED MODEL | 1.460 | 1.402 | Q3 | MATHEMATICAL & COMPUTATIONAL BIOLOGY | 31 | 58 |
| Theoretical Biology Forum | THEOR BIOL FORUM | 0.421 | 0.421 | Q4 | BIOLOGY | 77 | 84 |
| THEORETICAL CHEMISTRY ACCOUNTS | THEOR CHEM ACC | 1.890 | 1.781 | Q3 | CHEMISTRY, PHYSICAL | 86 | 145 |
| THEORETICAL FOUNDATIONS OF CHEMICAL ENGINEERING | THEOR FOUND CHEM EN+ | 0.494 | 0.281 | Q4 | ENGINEERING, CHEMICAL | 123 | 135 |
| THEORY IN BIOSCIENCES | THEOR BIOSCI | 0.778 | 0.667 | Q4 | BIOLOGY | 65 | 84 |
| THEORY IN BIOSCIENCES | THEOR BIOSCI | 0.778 | 0.667 | Q4 | MATHEMATICAL & COMPUTATIONAL BIOLOGY | 47 | 58 |
| Theranostics | THERANOSTICS | 8.712 | 8.156 | Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | 8 | 128 |
| Therapeutic Advances in Gastroenterology | THER ADV GASTROENTER | 3.648 | 3.574 | Q2 | GASTROENTEROLOGY & HEPATOLOGY | 22 | 79 |
| Therapeutic Advances in Medical Oncology | THER ADV MED ONCOL | 6.294 | 6.176 | Q1 | ONCOLOGY | 28 | 217 |
| THERAPEUTIC DRUG MONITORING | THER DRUG MONIT | 2.178 | 1.943 | Q3 | PHARMACOLOGY & PHARMACY | 153 | 256 |
| Therapeutic Innovation & Regulatory Science | THER INNOV REGUL SCI | 0.442 | 0.365 | Q4 | MEDICAL INFORMATICS | 23 | 23 |
| Therapeutic Innovation & Regulatory Science | THER INNOV REGUL SCI | 0.442 | 0.365 | Q4 | PHARMACOLOGY & PHARMACY | 249 | 256 |
| THERAPIE | THERAPIE | 0.926 | 0.649 | Q4 | PHARMACOLOGY & PHARMACY | 228 | 256 |
| THERIOGENOLOGY | THERIOGENOLOGY | 1.986 | 1.516 | Q3 | REPRODUCTIVE BIOLOGY | 20 | 29 |
| THERMOCHIMICA ACTA | THERMOCHIM ACTA | 2.236 | 2.027 | Q3 | CHEMISTRY, PHYSICAL | 78 | 145 |
| Thermophysics and Aeromechanics | THERMOPHYS AEROMECH+ | 0.747 | 0.610 | Q4 | MECHANICS | 115 | 133 |
| THIN SOLID FILMS | THIN SOLID FILMS | 1.879 | 1.759 | Q2 | MATERIALS SCIENCE, MULTIDISCIPLINARY | 135 | 275 |
| THIN SOLID FILMS | THIN SOLID FILMS | 1.879 | 1.759 | Q2 | PHYSICS, APPLIED | 65 | 147 |
| Thoracic Cancer | THORAC CANCER | 1.116 | 1.060 | Q4 | ONCOLOGY | 202 | 217 |
| TISSUE & CELL | TISSUE CELL | 1.232 | 1.174 | Q4 | CELL BIOLOGY | 171 | 189 |
| TISSUE ANTIGENS | TISSUE ANTIGENS | 1.596 | 1.596 | Q4 | CELL BIOLOGY | 161 | 189 |
| TISSUE ANTIGENS | TISSUE ANTIGENS | 1.596 | 1.596 | Q4 | IMMUNOLOGY | 128 | 150 |
| TISSUE ENGINEERING | TISSUE ENG | 3.485 | 3.181 | Q2 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 42 | 158 |
| TISSUE ENGINEERING | TISSUE ENG | 3.485 | 3.181 | Q2 | CELL & TISSUE ENGINEERING | 10 | 21 |
| TISSUE ENGINEERING | TISSUE ENG | 3.485 | 3.181 | Q2 | CELL BIOLOGY | 91 | 189 |
| Tissue Engineering and Regenerative Medicine | TISSUE ENG REGEN MED | 1.169 | 0.803 | Q4 | CELL & TISSUE ENGINEERING | 21 | 21 |
| Tissue Engineering and Regenerative Medicine | TISSUE ENG REGEN MED | 1.169 | 0.803 | Q3 | ENGINEERING, BIOMEDICAL | 54 | 77 |
| TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE | TOHOKU J EXP MED | 1.278 | 1.241 | Q4 | MEDICINE, RESEARCH & EXPERIMENTAL | 99 | 128 |
| Topics in Applied Physics | TOP APPL PHYS | 0.238 | 0.238 | Q4 | PHYSICS, APPLIED | 146 | 147 |
| TOPICS IN CATALYSIS | TOP CATAL | 2.486 | 2.402 | Q2 | CHEMISTRY, APPLIED | 20 | 72 |
| TOPICS IN CATALYSIS | TOP CATAL | 2.486 | 2.402 | Q2 | CHEMISTRY, PHYSICAL | 69 | 145 |
| Topics in Current Chemistry | TOPICS CURR CHEM | 4.033 | 4.019 | Q2 | CHEMISTRY, MULTIDISCIPLINARY | 43 | 166 |
| TOXICOLOGY | TOXICOLOGY | 3.582 | 3.456 | Q1 | PHARMACOLOGY & PHARMACY | 58 | 256 |
| TOXICOLOGY AND APPLIED PHARMACOLOGY | TOXICOL APPL PHARM | 3.791 | 3.649 | Q1 | PHARMACOLOGY & PHARMACY | 52 | 256 |
| TOXICON | TOXICON | 1.927 | 1.624 | Q3 | PHARMACOLOGY & PHARMACY | 168 | 256 |
| TRACE ELEMENTS AND ELECTROLYTES | TRACE ELEM ELECTROLY | 0.540 | 0.238 | Q4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 278 | 286 |
| TRAFFIC | TRAFFIC | 4.133 | 3.964 | Q2 | CELL BIOLOGY | 65 | 189 |
| Transactions of FAMENA | T FAMENA | 0.500 | 0.411 | Q4 | ENGINEERING, MECHANICAL | 116 | 130 |
| Transactions of FAMENA | T FAMENA | 0.500 | 0.411 | Q4 | MATERIALS SCIENCE, MULTIDISCIPLINARY | 249 | 275 |
| TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA | T NONFERR METAL SOC | 1.342 | 0.960 | Q2 | METALLURGY & METALLURGICAL ENGINEERING | 25 | 74 |
| TRANSACTIONS OF THE CANADIAN SOCIETY FOR MECHANICAL ENGINEERING | T CAN SOC MECH ENG | 0.353 | 0.304 | Q4 | ENGINEERING, MECHANICAL | 120 | 130 |
| TRANSACTIONS OF THE INDIAN INSTITUTE OF METALS | T INDIAN I METALS | 0.533 | 0.480 | Q4 | METALLURGY & METALLURGICAL ENGINEERING | 56 | 74 |
| TRANSACTIONS OF THE INSTITUTE OF METAL FINISHING | T I MET FINISH | 0.802 | 0.646 | Q3 | METALLURGY & METALLURGICAL ENGINEERING | 43 | 74 |
| TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES | T JPN SOC AERONAUT S | 0.541 | 0.424 | Q4 | ENGINEERING, AEROSPACE | 25 | 31 |
| TRANSACTIONS OF THE ROYAL SOCIETY OF SOUTH AUSTRALIA | T ROY SOC SOUTH AUST | 0.763 | 0.579 | Q3 | MULTIDISCIPLINARY SCIENCES | 42 | 64 |
| TRANSFUSION CLINIQUE ET BIOLOGIQUE | TRANSFUS CLIN BIOL | 0.741 | 0.568 | Q4 | IMMUNOLOGY | 148 | 150 |
| TRANSFUSION MEDICINE AND HEMOTHERAPY | TRANSFUS MED HEMOTH | 1.760 | 1.640 | Q4 | IMMUNOLOGY | 123 | 150 |
| TRANSGENIC RESEARCH | TRANSGENIC RES | 2.341 | 2.176 | Q3 | BIOCHEMICAL RESEARCH METHODS | 43 | 77 |
| TRANSGENIC RESEARCH | TRANSGENIC RES | 2.341 | 2.176 | Q3 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 180 | 286 |
| TRANSGENIC RESEARCH | TRANSGENIC RES | 2.341 | 2.176 | Q2 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 71 | 158 |
| Translational Cancer Research | TRANSL CANCER RES | 1.167 | 1.125 | Q4 | ONCOLOGY | 199 | 217 |
| Translational Oncology | TRANSL ONCOL | 3.025 | 2.949 | Q2 | ONCOLOGY | 107 | 217 |
| Translational Research | TRANSL RES | 4.652 | 4.471 | Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | 19 | 128 |
| TRANSPLANT IMMUNOLOGY | TRANSPL IMMUNOL | 1.780 | 1.715 | Q4 | IMMUNOLOGY | 122 | 150 |
| Transplant Infectious Disease | TRANSPL INFECT DIS | 1.719 | 1.580 | Q4 | IMMUNOLOGY | 124 | 150 |
| TRANSPLANTATION | TRANSPLANTATION | 3.678 | 3.285 | Q2 | IMMUNOLOGY | 54 | 150 |
| TRANSPLANTATION PROCEEDINGS | TRANSPL P | 0.908 | 0.755 | Q4 | IMMUNOLOGY | 143 | 150 |
| Transplantation Reviews | TRANSPLANT REV-ORLAN | 3.113 | 2.984 | Q2 | IMMUNOLOGY | 73 | 150 |
| TRANSPORT IN POROUS MEDIA | TRANSPORT POROUS MED | 2.205 | 1.985 | Q2 | ENGINEERING, CHEMICAL | 50 | 135 |
| TRENDS IN BIOCHEMICAL SCIENCES | TRENDS BIOCHEM SCI | 16.630 | 16.449 | Q1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 4 | 286 |
| TRENDS IN BIOTECHNOLOGY | TRENDS BIOTECHNOL | 11.126 | 10.853 | Q1 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 5 | 158 |
| TRENDS IN CELL BIOLOGY | TRENDS CELL BIOL | 15.333 | 15.192 | Q1 | CELL BIOLOGY | 10 | 189 |
| TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY | TRENDS GLYCOSCI GLYC | 0.345 | 0.345 | Q4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 281 | 286 |
| TRENDS IN IMMUNOLOGY | TRENDS IMMUNOL | 13.287 | 13.088 | Q1 | IMMUNOLOGY | 5 | 150 |
| TRENDS IN MICROBIOLOGY | TRENDS MICROBIOL | 11.020 | 10.872 | Q1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 10 | 286 |
| TRENDS IN MOLECULAR MEDICINE | TRENDS MOL MED | 10.732 | 10.641 | Q1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 12 | 286 |
| TRENDS IN MOLECULAR MEDICINE | TRENDS MOL MED | 10.732 | 10.641 | Q1 | CELL BIOLOGY | 14 | 189 |
| TRENDS IN MOLECULAR MEDICINE | TRENDS MOL MED | 10.732 | 10.641 | Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | 6 | 128 |
| TRENDS IN PHARMACOLOGICAL SCIENCES | TRENDS PHARMACOL SCI | 12.797 | 12.601 | Q1 | PHARMACOLOGY & PHARMACY | 5 | 256 |
| Trials | TRIALS | 1.969 | 1.809 | Q3 | MEDICINE, RESEARCH & EXPERIMENTAL | 78 | 128 |
| TRIBOLOGY & LUBRICATION TECHNOLOGY | TRIBOL LUBR TECHNOL | 0.136 | 0.059 | Q4 | ENGINEERING, MECHANICAL | 129 | 130 |
| TRIBOLOGY INTERNATIONAL | TRIBOL INT | 2.903 | 1.964 | Q1 | ENGINEERING, MECHANICAL | 18 | 130 |
| TRIBOLOGY LETTERS | TRIBOL LETT | 1.891 | 1.623 | Q2 | ENGINEERING, CHEMICAL | 59 | 135 |
| TRIBOLOGY LETTERS | TRIBOL LETT | 1.891 | 1.623 | Q2 | ENGINEERING, MECHANICAL | 43 | 130 |
| TRIBOLOGY TRANSACTIONS | TRIBOL T | 1.685 | 1.249 | Q2 | ENGINEERING, MECHANICAL | 52 | 130 |
| TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH | TROP J PHARM RES | 0.569 | 0.517 | Q4 | PHARMACOLOGY & PHARMACY | 245 | 256 |
| TUBERCULOSIS | TUBERCULOSIS | 2.873 | 2.684 | Q3 | IMMUNOLOGY | 82 | 150 |
| TUMOR BIOLOGY | TUMOR BIOL | 3.650 | 3.242 | Q2 | ONCOLOGY | 81 | 217 |
| TUMORI | TUMORI | 1.233 | 1.160 | Q4 | ONCOLOGY | 197 | 217 |
| Turkish Journal of Biochemistry-Turk Biyokimya Dergisi | TURK J BIOCHEM | 0.216 | 0.209 | Q4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 284 | 286 |
| TURKISH JOURNAL OF BIOLOGY | TURK J BIOL | 1.038 | 0.820 | Q3 | BIOLOGY | 58 | 84 |
| TURKISH JOURNAL OF CHEMISTRY | TURK J CHEM | 1.292 | 1.146 | Q3 | CHEMISTRY, MULTIDISCIPLINARY | 106 | 166 |
| TURKISH JOURNAL OF CHEMISTRY | TURK J CHEM | 1.292 | 1.146 | Q3 | ENGINEERING, CHEMICAL | 78 | 135 |
| Turkish Journal of Gastroenterology | TURK J GASTROENTEROL | 0.932 | 0.852 | Q4 | GASTROENTEROLOGY & HEPATOLOGY | 71 | 79 |
